Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
104,829
-
Share change
-
-14,801
-
Total reported value
-
$8,738,642
-
Put/Call ratio
-
95%
-
Price per share
-
$78.82
-
Number of holders
-
21
-
Value change
-
-$2,121,035
-
Number of buys
-
14
-
Number of sells
-
12
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2025
As of 30 Jun 2025,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,829 shares.
The largest 10 holders included
Virtu Financial LLC, CITADEL ADVISORS LLC, Bullseye Investment Management, LLC, SBI Securities Co., Ltd., GTS SECURITIES LLC, Traynor Capital Management, Inc., ROVIN CAPITAL /UT/ /ADV, Tower Research Capital LLC (TRC), EverSource Wealth Advisors, LLC, and Qube Research & Technologies Ltd.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.